SectorLife Science Tools and Services
Established Date01/03/2021
Listing Date08/12/2022
ExchangeNASDAQ Stock Exchange
Full-time Employees0
Fiscal Year Ends30/09
Security TypeCommon stock
Office address11 Commerce Drive, First Floor, Cranford, NJ 07016
Business
IntroductionCitius Oncology, Inc. (formerly TenX Keane Acquisition) was incorporated in the Cayman Islands on March 1, 2021, and was relocated and naturalized as a Delaware company on August 5, 2024. Citius Oncology will serve as a platform to develop and commercialize novel targeted tumor therapies. In August 2024, its main asset, LYMPHIR, received FDA approval for the treatment of adult patients with relapsed or refractory CTCL who have received at least one systemic treatment.
